Prospects for the Development of Long-Acting Formulations of Human Somatropin

Author： Jostel Andreas   Shalet Stephen M.  

Publisher： Adis International

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.5, Iss.3, 2006-01, pp. : 139-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing Somatostatin Analog Therapy in Acromegaly: Long-Acting Formulations

By Gilroy J.J.  

Treatments in Endocrinology, Vol. 1, Iss. 3, 2002-03 ,pp. : 149-154

Adis International

Access to resources Recommend Favorite

Development and characterization of a long‐acting recombinant hFSH agonist

By Klein J.  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 50-56

Oxford University Press

Access to resources Recommend Favorite

Spotlight on Octreotide Long-Acting Release (LAR) in Acromegaly

By McKeage Kate   Cheer Susan   Wagstaff Antona J.  

Treatments in Endocrinology, Vol. 3, Iss. 3, 2004-01 ,pp. : 197-200

Adis International

Access to resources Recommend Favorite

Long-Acting -Agonists: Comparative Pharmacology and Clinical Outcomes

By van der Woude H.J.   Aalbers R.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 1, 2002-01 ,pp. : 55-74

Adis International

Access to resources Recommend Favorite

Long-Term Management of Prolactinomas—Use of Long-Acting Dopamine Agonists

By Cook David  

Reviews in Endocrine and Metabolic Disorders, Vol. 6, Iss. 1, 2005-01 ,pp. : 15-21

Springer Publishing Company

Access to resources Recommend Favorite